For example, respondents may have initially stated that they never used prescription medication to treat their headaches, but then reported in a subsequent question that they kept specific prescription medications on hand. The analysis population was further refined to remove respondents with contradictory responses regarding acute prescription medication use. Respondents selecting acute prescription medication in answer to both questions were categorized as current users. Those who endorsed this initial question were asked, “Which are you currently using (or have on hand) for your headaches?” Respondents selecting acute prescription medication as an answer for only the first question were classified as discontinued users. Based on endorsement of “Prescription pain medication that you take when you get a headache (or feel one coming on),” respondents were classified as having ever used or never used acute prescription medication. The question “Which of the following types of headache treatments have you ever used to treat or manage your headache pain?” was used to stratify the sample. Throughout the survey, the term “headache” was used because not all respondents were aware that they met the criteria for migraine or that it had been diagnosed. Classification of respondents as current users, discontinued users, or never users of acute prescription medication to treat headache pain was performed based on responses to questions from the barriers-to-care module. Conclusionĭemographic information was collected as part of the screening module. The most commonly reported prescription medications used or “kept on hand” by current users were triptans (47.2% 1474 of 3121), opioids (37.3% 1164 of 3121), nonsteroidal anti-inflammatory drugs (31.9% 997 of 3121), and barbiturates (12.8% 399 of 3121), with many people reporting more than 1 medication. Current users also had the highest scores on the depression and anxiety questionnaires. Current users experienced the highest degree of migraine-related disability based on Migraine Disability Assessment scores and the highest levels of migraine symptom severity based on Migraine Symptom Severity Scale scores. Mean ± SD monthly headache frequency was 7.3☗.1 days for current users, 5.6☖.6 days for those who discontinued, and 3.9±4.9 days for respondents who never used acute prescription medication for migraine. Data from 13,624 respondents were analyzed, including 3121 (22.9%) self-reported current users of acute prescription medication for migraine, 1719 (12.6%) previous/discontinued users, and 8784 (64.5%) who had never used acute prescription medication for migraine.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |